APA (7th ed.) Citation

Amri H, Haramati A, & Abu-Asab M. (2012). P02.59. Complexity of disease and population heterogeneity require a rethinking of clinical trial design. BMC.

Chicago Style (17th ed.) Citation

Amri H, Haramati A, and Abu-Asab M. P02.59. Complexity of Disease and Population Heterogeneity Require a Rethinking of Clinical Trial Design. BMC, 2012.

MLA (9th ed.) Citation

Amri H, et al. P02.59. Complexity of Disease and Population Heterogeneity Require a Rethinking of Clinical Trial Design. BMC, 2012.